Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Apellis Pharmaceuticals, Inc. has filed 1,229 SEC EDGAR filings since 21 May 2010

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
4

4

Filing date
02 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Sep 2025
Reporting date
19 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
19 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Sep 2025
Reporting date
16 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Sep 2025
Reporting date
15 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
16 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
15 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Sep 2025
Reporting date
10 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
10 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Sep 2025
Reporting date
08 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
08 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
08 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Sep 2025
Reporting date
02 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Sep 2025
Reporting date
02 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
02 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Sep 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
02 Sep 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Aug 2025
Reporting date
27 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
27 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Aug 2025
Reporting date
18 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38276

144 filing

Filing date
18 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90187

SCHEDULE 13G/A filing

Filing date
12 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Jul 2025
Reporting date
17 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Jul 2025
Reporting date
16 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .